Assistant Professor, Surgery, University of Louisville School of Medicine
General Surgery
Dr. Glenda Callender, MD
|
|
Give Review
Glenda Callender is an expert in the field of General Surgery. She went to medical school at Harvard Medical School. Harvard Medical School is a one of the best medicals schools. Harvard Medical School has a rank of 1 in research and a 12 in primary care She received 2 awards: "CMS Meaningful Use Stage 1 Certification" and "Fellow". Glenda Callender is a published doctor as well. She has 41 publications published. The latest was: Hepatitis C virus-cross-reactive TCR gene-modified T cells: a model for immunotherapy against diseases with genomic instability. She accepts Medicare.
Publications
- Hepatitis C virus-cross-reactive TCR gene-modified T cells: a model for immunotherapy against Diseases with genomic instability.
- Maintenance of certification: what everyone needs to know.
- Surgery for primary Hyperparathyroidism.
- Surgery for Thyroid Cancer.
- Prognostic factors in young women with cutaneous melanoma.
- Outcomes and prognostic factors in superficial spreading melanoma.
- Current management of melanoma.
- Incidence of sentinel lymph node involvement in a modern, large series of desmoplastic melanoma.
- Evaluation of Alpha-fetoprotein Staging System for Hepatocellular Carcinoma in Noncirrhotic Patients.
- Financial Comparison of Laparoscopic Versus Open Hepatic Resection Using Deviation-Based Cost Modeling.
- Diversity of stage III melanoma in the era of sentinel lymph node biopsy.
- Assessment of Chemotherapy Response in Colorectal Liver Metastases in Patients Undergoing Hepatic Resection and the Correlation to Pathologic Residual Viable Tumor.
- A Phase 2 Trial of Once-Weekly Hypofractionated Breast Irradiation: First Report of Acute Toxicity, Feasibility, and Patient Satisfaction.
- Assessment of mitotic rate reporting in melanoma.
- Unique prognostic factors in acral lentiginous melanoma.
- The lymph node ratio has limited prognostic significance in melanoma.
- Clinicopathologic and survival differences between upper and lower extremity melanomas.
- Prognostic implications of anatomic location of primary cutaneous melanoma of 1 mm or thicker.
- Regression does not predict nodal metastasis or survival in patients with cutaneous melanoma.
- LymphoVascular invasion as a prognostic factor in melanoma.
- Safety and efficacy of hepatectomy for Colorectal metastases in the elderly.
- Recurrence Following Hepatectomy for Metastatic Colorectal Cancer: Development of a Model that Predicts Patterns of Recurrence and Survival.
- Common locations of Parathyroid adenomas.
- Early versus delayed complete lymphadenectomy in melanoma: insight from MSLT I.
- What does ulceration of a melanoma mean for prognosis?
- Local excision after preoperative chemoradiation results in an equivalent outcome to total mesorectal excision in selected patients with T3 rectal Cancer.
- Recurrence of Adrenal cortical carcinoma following resection: surgery alone can achieve results equal to surgery plus mitotane.
- The fallen one: the inferior parathyroid Gland that descends into the mediastinum.
- Posterior retroperitoneoscopic Adrenalectomy.
- Multiple endocrine neoplasia syndromes.
- Structural basis for the recognition of mutant self by a Tumor-specific, MHC class II-restricted T cell receptor.
- Identification of a hepatitis C virus-reactive T cell receptor that does not require CD8 for target cell recognition.
- Retroviral transduction of peptide stimulated t cells can generate dual t cell receptor-expressing (bifunctional) t cells reactive with two defined antigens.
- Cutting edge: identification of hepatitis C virus-specific CD8+ T cells restricted by donor HLA alleles following Liver transplantation.
- Readmission rates after Abdominal surgery: the role of surgeon, primary caregiver, home health, and subacute rehab.
- Paraganglioma syndrome type 1 in a patient with Carney-Stratakis syndrome.
- CD34-based enrichment of genetically engineered human T cells for clinical use results in dramatically enhanced Tumor targeting.
- Interferon-gamma renders Tumors that express low levels of Her-2/neu sensitive to cytotoxic T cells.
- Detection of human perforin by ELISpot and ELISA: ex vivo identification of virus-specific cells.
- A new murine Tumor model for studying HLA-A2-restricted anti-Tumor immunity.
Procedures Preformed
- Adrenalectomy
- Biopsy of Breast
- Excision, Shaving, or Destruction of Skin and Subcutaneous Tissue (incl. Mohs Micrographic Surgery), Tissue Transfer
- Intestinal Transplant (incl. Enterectomy)
- View All
Conditions Treated
- Abdominal Pain
- Adrenal Gland Cancer
- Atelectasis
- Breast Cancer
- View All
Doctors Specialties
- General Surgery
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Fellow
Education
-
University of Chicago -
Harvard Medical School
Hospital
-
Norton Hospital -
University of Louisville Hospital
Drug Facts
| NPI NUMBER | 1952599441 | |
| NPPES Provider LastName | CALLENDER | |
| NPPES Provider FirstName | GLENDA | |
| NPPES Provider ZIPCode | 065103218 | |
| NPPES Provider State | CT | |
| Specialty Description | General Surgery | |
| Total Claim Count | 14.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1952599441 |
| Last Name Of The Provider | CALLENDER |
| First Name Of The Provider | GLENDA |
| View All |
Similar Doctors
|
|
Dr. Anthony George Jr., MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ben A. Reid Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Cathryn A. Doughtie, MD |
|
|
Dr. Fredrik P. Tolin, MD |
|
Dr. Richard N. Garrison, MD |
|
|
Dr. Mary B. Carter, MD |